Fulcrum Therapeutics Issues Stock Options to Attract Talent

Cambridge, Friday, 12 September 2025.
Fulcrum Therapeutics, a biopharmaceutical firm, grants stock options under Nasdaq rules to attract key talent, emphasizing its dedication to innovation and growth in rare disease treatment.